LKFT
Lakefront Biotherapeutics - American Depositary Shares (LKFT)
$99
About Lakefront Biotherapeutics - American Depositary Shares (LKFT)
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Details
Daily high
$28.03
Daily low
$27.30
Price at open
$27.54
52 Week High
$37.78
52 Week Low
$25.68
Market cap
1.8B
Dividend yield
-
Volume
329,244
Avg. volume
239,588
P/E ratio
2.61
Lakefront Biotherapeutics - American Depositary Shares News
Details
Daily high
$28.03
Daily low
$27.30
Price at open
$27.54
52 Week High
$37.78
52 Week Low
$25.68
Market cap
1.8B
Dividend yield
-
Volume
329,244
Avg. volume
239,588
P/E ratio
2.61